Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone V Bigi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|November 19, 2025
Structural Biology Enabling Drug DiscoveryDavid E Heppner, Simone V Bigi-Botterill, Andrew P Riley, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Fifteen Years, One Mission: Innovative, Inspirational, and Impactful DiscoveriesSimone V Bigi-Botterill, Chiara Borsari, Amanda W Dombrowski, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp<sup>3</sup> character and an exquisite selectivity profileSimone V Bigi-Botterill, Anthony Ivetac, Erica L Bradshaw, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2015
Fragment-based drug discovery of potent and selective MKK3/6 inhibitorsMark Adams, Toshitake Kobayashi, J David Lawson, et al.
Journal of Medicinal Chemistry|February 28, 2018
Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic RelationshipsMasato Yoshikawa, Morihisa Saitoh, Taisuke Katoh, et al.
Journal of Medicinal Chemistry|March 30, 2021
Synthetic Approaches to the New Drugs Approved during 2019Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart FailureMarion Lanier, Jason Pickens, Simone V Bigi, et al.
Journal of Medicinal Chemistry|July 14, 2022
Synthetic Approaches to the New Drugs Approved During 2020Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Correction to "Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure"Marion Lanier, Jason Pickens, Simone V Bigi, et al.
Journal of Medicinal Chemistry|June 14, 2024
Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1Mark Sabat, Daniel W Carney, Gloria Hernandez-Torres, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|November 19, 2025
Structural Biology Enabling Drug DiscoveryDavid E Heppner, Simone V Bigi-Botterill, Andrew P Riley, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Fifteen Years, One Mission: Innovative, Inspirational, and Impactful DiscoveriesSimone V Bigi-Botterill, Chiara Borsari, Amanda W Dombrowski, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp<sup>3</sup> character and an exquisite selectivity profileSimone V Bigi-Botterill, Anthony Ivetac, Erica L Bradshaw, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2015
Fragment-based drug discovery of potent and selective MKK3/6 inhibitorsMark Adams, Toshitake Kobayashi, J David Lawson, et al.
Journal of Medicinal Chemistry|February 28, 2018
Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic RelationshipsMasato Yoshikawa, Morihisa Saitoh, Taisuke Katoh, et al.
Journal of Medicinal Chemistry|March 30, 2021
Synthetic Approaches to the New Drugs Approved during 2019Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart FailureMarion Lanier, Jason Pickens, Simone V Bigi, et al.
Journal of Medicinal Chemistry|July 14, 2022
Synthetic Approaches to the New Drugs Approved During 2020Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Correction to "Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure"Marion Lanier, Jason Pickens, Simone V Bigi, et al.
Journal of Medicinal Chemistry|June 14, 2024
Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1Mark Sabat, Daniel W Carney, Gloria Hernandez-Torres, et al.
Pageof 1